LY007
LY007C1101
Phase 1 small_molecule active
Quick answer
LY007 for B-NHL is a Phase 1 program (small_molecule) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- First Tracks Biotherapeutics
- Indication
- B-NHL
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active